@article{11b635657c2041a681de31ddac67d684,
title = "The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience",
author = "P. Jain and H. Kantarjian and F. Ravandi and D. Thomas and S. O'Brien and T. Kadia and J. Burger and G. Borthakur and N. Daver and E. Jabbour and M. Konopleva and J. Cortes and N. Pemmaraju and Kelly, {M. A.} and M. Cardenas-Turanzas and R. Garris and S. Faderl",
note = "Funding Information: This study was supported partly by GlaxoSmithKline Pharmaceuticals (to SF).",
year = "2014",
month = apr,
doi = "10.1038/leu.2013.312",
language = "English (US)",
volume = "28",
pages = "973--975",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "4",
}